Literature DB >> 10965500

Oestrogen receptor function at classical and alternative response elements.

P J Kushner1, D Agard, W J Feng, G Lopez, A Schiau, R Uht, P Webb, G Greene.   

Abstract

The oestrogen receptor (ER), bound to classical response elements (EREs) in the promoter of target genes, activates transcription by recruiting coactivator proteins. We will describe structural studies that show that oestrogens allow the formation of a hydrophobic cleft on the surface of the ER that serves as a docking site for coactivators. Anti-oestrogens displace part of the receptor, which then occludes the site, blocking coactivator access. In addition to activating at classical EREs, the ER activates transcription at alternative elements such as AP-1 sites. These bind the Jun/Fos proteins but not ER. Interestingly both oestrogen and tamoxifen activate transcription at AP-1 sites. We propose a mechanism whereby oestrogen and anti-oestrogen allow ER to activate transcription from alternative response elements. ER binds to the coactivators, CBP and GRIP1, that have been recruited by Jun/Fos and through this contact 'triggers' these coactivators into full activity. In this circumstance the ER is part of the coactivator complex for Jun/Fos.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965500     DOI: 10.1002/0470870818.ch3

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  19 in total

1.  Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.

Authors:  Chunyu Wang; Julie Ann Mayer; Abhijit Mazumdar; Kirsten Fertuck; Heetae Kim; Myles Brown; Powel H Brown
Journal:  Mol Endocrinol       Date:  2011-08-11

Review 2.  Integration of the extranuclear and nuclear actions of estrogen.

Authors:  Ellis R Levin
Journal:  Mol Endocrinol       Date:  2005-02-10

Review 3.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 4.  Bioactivation of Selective Estrogen Receptor Modulators (SERMs).

Authors:  Tamara S Dowers; Zhi-Hui Qin; Gregory R J Thatcher; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2006-09       Impact factor: 3.739

Review 5.  Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy.

Authors:  Eugene D Albrecht; Gerald J Pepe
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

6.  Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.

Authors:  Ammar Abou-Kandil; Nora Eisa; Azhar Jabareen; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

7.  Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy.

Authors:  Thomas W Bonagura; Gerald J Pepe; Allen C Enders; Eugene D Albrecht
Journal:  Endocrinology       Date:  2008-06-19       Impact factor: 4.736

Review 8.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

Review 9.  Nervous system physiology regulated by membrane estrogen receptors.

Authors:  Paul G Mermelstein; Paul E Micevych
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

10.  Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.

Authors:  Yong Zhang; Donald Y M Leung; Steven K Nordeen; Elena Goleva
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.